The latest price target for Incyte (NASDAQ:INCY) was reported by Morgan Stanley on December 8, 2025. The analyst firm set a price target for $92.00 expecting INCY to fall to within 12 months (a possible -6.13% downside). 46 analyst firms have reported ratings in the last year.

The latest analyst rating for Incyte (NASDAQ:INCY) was provided by Morgan Stanley, and Incyte maintained their equal-weight rating.

The last upgrade for Incyte Corp happened on December 8, 2025 when Mizuho raised their price target to $121. Mizuho previously had a neutral for Incyte Corp.

The last downgrade for Incyte Corp happened on March 18, 2025 when Guggenheim changed their price target from $92 to $92 for Incyte Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Incyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Incyte was filed on December 8, 2025 so you should expect the next rating to be made available sometime around December 8, 2026.

While ratings are subjective and will change, the latest Incyte (INCY) rating was a maintained with a price target of $86.00 to $92.00. The current price Incyte (INCY) is trading at is $98.01, which is out of the analyst’s predicted range.